Literature DB >> 1776825

Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamin derivative.

R Bitsch1, M Wolf, J Möller, L Heuzeroth, D Grüneklee.   

Abstract

The bioequivalence of thiamin in 2 therapeutically used preparations was tested in 10 healthy young men. Thiamin was orally administered either as lipophilic benfotiamine or as water-soluble thiamin mononitrate. Biokinetic data, measured as area under the curve and maximal concentration in plasma and hemolysate after ingestion, demonstrated a significantly improved bioavailability from the lipophilic derivative despite an ingested dose of only 40% as compared with the water-soluble salt. A superior cellular efficacy of benfotiamine was also concluded from the short-term stimulation of the thiamin-dependent transketolase activity in erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1776825     DOI: 10.1159/000177659

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  12 in total

1.  Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis.

Authors:  Lars P Kihm; Sandra Müller-Krebs; Julia Klein; Gregory Ehrlich; Laura Mertes; Marie-Luise Gross; Antonysunil Adaikalakoteswari; Paul J Thornalley; Hans-Peter Hammes; Peter P Nawroth; Martin Zeier; Vedat Schwenger
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

Review 2.  Targeting advanced glycation with pharmaceutical agents: where are we now?

Authors:  Danielle J Borg; Josephine M Forbes
Journal:  Glycoconj J       Date:  2016-07-09       Impact factor: 2.916

3.  Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence.

Authors:  Ann M Manzardo; Jianghua He; Albert Poje; Elizabeth C Penick; Jan Campbell; Merlin G Butler
Journal:  Drug Alcohol Depend       Date:  2013-08-11       Impact factor: 4.492

4.  Change in psychiatric symptomatology after benfotiamine treatment in males is related to lifetime alcoholism severity.

Authors:  Ann M Manzardo; Tiffany Pendleton; Albert Poje; Elizabeth C Penick; Merlin G Butler
Journal:  Drug Alcohol Depend       Date:  2015-04-08       Impact factor: 4.492

Review 5.  Vitamin B1 (thiamine) and dementia.

Authors:  Gary E Gibson; Joseph A Hirsch; Pasquale Fonzetti; Barry D Jordan; Rosanna T Cirio; Jessica Elder
Journal:  Ann N Y Acad Sci       Date:  2016-03-11       Impact factor: 5.691

6.  Prevention of endotoxin-induced uveitis in rats by benfotiamine, a lipophilic analogue of vitamin B1.

Authors:  Umesh C S Yadav; Sumitra Subramanyam; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-10       Impact factor: 4.799

7.  Benfotiamine attenuates inflammatory response in LPS stimulated BV-2 microglia.

Authors:  Iva Bozic; Danijela Savic; Danijela Laketa; Ivana Bjelobaba; Ivan Milenkovic; Sanja Pekovic; Nadezda Nedeljkovic; Irena Lavrnja
Journal:  PLoS One       Date:  2015-02-19       Impact factor: 3.240

8.  A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives.

Authors:  Derrick Lonsdale
Journal:  Evid Based Complement Alternat Med       Date:  2006-03       Impact factor: 2.629

9.  Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives.

Authors:  Marie-Laure Volvert; Sandrine Seyen; Marie Piette; Brigitte Evrard; Marjorie Gangolf; Jean-Christophe Plumier; Lucien Bettendorff
Journal:  BMC Pharmacol       Date:  2008-06-12

10.  Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells.

Authors:  Iva Bozic; Danijela Savic; Ivana Stevanovic; Sanja Pekovic; Nadezda Nedeljkovic; Irena Lavrnja
Journal:  Front Cell Neurosci       Date:  2015-09-04       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.